Sanofi has stated that it does not anticipate job losses as a result of the restructuring, according to a report in French newspaper Les Echos. Brandicourt said the new structure "simplifies and ...

French drugmaker Sanofi has confirmed its plan to spend €1.3bn on an insulin factory at its site near Frankfurt, website ...

Located in the eastern part of France in Neuville-sur-Saone, the facility is “revolutionary” and the first of its kind in the world, according to Sanofi. The factory can manufacture up to four ...

For the past few years, Sanofi has stayed out of the obesity drug development bonanza, taking a wait-and-see approach while ...

The French drugmaker has stayed on the sidelines as a who’s who of drugmakers, led by Novartis, have placed big bets on radioligand therapies. Sanofi is entering the sector through a deal with ...

Sanofi's (SNY) plans to seperate its consumer care unit draws buyout bids with over €10B in funding committed from banks and ...

Sanofi has asked bidders to revise their proposals ... as it considers whether to seek a sale or listing of the business. The French company asked suitors to submit revised bids for the Opella ...

It also means Fulcrum can wave goodbye to potentially $975 million in milestone payments that were tied to the Sanofi licensing deal. When the French Pharma secured the ex-U.S. rights to ...

Sanofi has announced the inauguration of its new modular vaccine and biomedicine production unit, Modulus, in Neuville-sur-Saône, France. Its standardised mini-factories equipped with ...

Sept 27 (Reuters) - The U.S. Food and Drug Administration has approved Sanofi (SASY.PA), opens new tab and Regeneron's (REGN.O), opens new tab blockbuster drug Dupixent for patients with a chronic ...

(Reuters) -Sanofi has received two separate bids from ... Bloomberg News reported on Tuesday. The French pharmaceutical company is likely to make a final decision on the unit in the coming days ...

Sanofi is following several of its big pharma industry peers into radiopharmaceuticals, striking a deal for a clinical-stage therapy now in discussion for a regulatory submission as a treatment ...